삼성서울병원

Ko En

Radiation Oncology Noh, Jae Myung M.D

Expertise
Lung cancer, esophageal cancer, thymic cancer, thyroid cancer, proton therapy
Treament Schedule 05 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
SAT
31
AM
PM
Treament Schedule 06 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
AM
PM

Medical Education

2012~2017 Ph.D. in Medicine Sungkyunkwan University, Korea
2006~2008 Master of Science Sungkyunkwan University, Korea
1998~2004 M.D. College of Medicine, Sungkyunkwan University, Korea

Post-Graduate Training

Fellowship   2012~2014 Department of Radiation Oncology, Samsung Medical Center
Residency   2005~2009 Department of Radiation Oncology, Samsung Medical Center
Internship   2004~2005 Samsung Medical Center

Professional Appointments

2020~Present Associate Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2016~2020 Assistant Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2014~2016 Clinical Instructor Department of Radiation Oncology, Sungkyunkwan University School of Medicine

Professional Memberships

2017~Present Member Korean Cancer Association
2017~Present Member Korean Society for Head & Neck Oncology
2014~Present Member Korean Association for Lung Cancer
2013~Present Member Korean Society of Medical Oncology
2005~Present Member Korean Society for Radiation Oncology

Selected Publications

  • CANCER RES TREAT 2025 10.4143/crt.2024.191 Salvage Radiotherapy for Loco-regional Recurrence of Esophageal Cancer Following Surgery Cho, WK; Noh, JM; Oh, D; Ahn, YC; Sun, JM; Kim, HK; Shim, YM
    View PubMed
  • RADIOTHER ONCOL 2024 10.1016/j.radonc.2024.110566 Development of learning-based predictive models for radiation-induced atrial fibrillation in non-small cell lung cancer patients by integrating patient-specific clinical, dosimetry, and diagnostic information Yoo, SK; Kim, KH; Noh, JM; Oh, J; Yang, G; Kim, J; Kim, N; Kim, H; Yoon, HI
    View PubMed
  • J GASTROINTEST SURG 2024 10.1016/j.gassur.2024.07.026 Comparison of the treatment outcomes of different neoadjuvant chemoradiotherapy regimens for resectable locally advanced esophageal cancer Park, H; Yang, KYM; Noh, JM; Shim, YM; Kim, HK; Choi, YS; Cho, JH; Sun, JM; Jung, HA; Park, S; Park, H; Oh, D
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2024.084 Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial Shin, J; Park, S; Kim, KH; Shin, EC; Jung, HA; Cho, JH; Sun, JM; Lee, SH; Choi, YS; Ahn, JS; Kim, J; Park, K; Shim, YM; Kim, HK; Noh, JM; Ahn, YC; Pyo, H; Ahn, MJ
    View PubMed
  • RADIOTHER ONCOL 2024 10.1016/j.radonc.2024.110436 Reduced frequency and severity of radiation esophagitis without marginal failure risk by contralateral esophagus sparing IMRT in stage III non-small cell lung cancer patients undergoing definitive concurrent chemoradiotherapy Lim, HS; Yang, K; Noh, JM; Pyo, H; Kim, JM; Kwon, D; Ju, SG; Ahn, YC
    View PubMed
  • CANCERS 2024 10.3390/cancers16112127 Dose-Escalated Radiotherapy for Primary Tracheobronchial Adenoid Cystic Carcinoma Lee, JH; Jang, JY; Noh, JM; Yang, K; Pyo, H
    View PubMed
  • J CACHEXIA SARCOPENI 2024 10.1002/jcsm.13462 Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy Jang, JY; Oh, D; Noh, JM; Sun, JM; Kim, HK; Shim, YM
    View PubMed
  • ECLINICALMEDICINE 2024 10.1016/j.eclinm.2024.102478 Role of invasive mediastinal nodal staging in survival outcomes of patients with non-small cell lung cancer and without radiologic lymph node metastasis: a retrospective cohort study Kim, HK; Jeon, YJ; Um, SW; Shin, SH; Jeong, BH; Lee, K; Kim, H; Lee, HY; Kim, TJ; Lee, KS; Choi, YL; Han, JH; Ahn, YC; Pyo, H; Noh, JM; Choi, JY; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Hwang, SS; Kim, J
    View PubMed
  • FRONT ONCOL 2024 10.3389/fonc.2024.1296172 Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer Yang, K; Noh, JM; Park, HY; Yoo, H; Shin, SH; Pyo, H
    View PubMed
  • RADIOTHER ONCOL 2023 10.1016/j.radonc.2023.109982 Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis Kim, K; Oh, D; Noh, JM; Min, YW; Kim, HK; Ahn, YC
    View PubMed
  • INT J RADIAT ONCOL 2023 10.1016/j.ijrobp.2023.05.038 Can Definitive Radiation Therapy Substitute Surgical Resection in Locally Advanced T3 or T4 Sinonasal Squamous Cell Carcinoma? Kim, K; Ahn, YC; Oh, D; Noh, JM; Jeong, HS; Chung, MK; Hong, SD; Baek, CH
    View PubMed
  • THORAC CANCER 2023 10.1111/1759-7714.15156 Quantification of diffuse parenchymal lung disease in non-small cell lung cancer patients with definitive concurrent chemoradiation therapy for predicting radiation pneumonitis An, YC; Kim, JH; Noh, JM; Yang, KM; Oh, YJ; Park, SG; Pyo, HR; Lee, HY
    View PubMed
  • RADIOTHER ONCOL 2023 10.1016/j.radonc.2023.109936 Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21-10) Song, JY; Moon, SH; Suh, YG; Kim, JH; Oh, D; Noh, JM; Jeong, JU; Cho, IJ; Kang, MK; Kim, JH; Kimi, YS; Kimj, HJ; Park, WY; Kim, BH; Kim, HJ
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.1305 The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer Choi, Y; Noh, JM; Shin, SH; Lee, KYJ; Um, SW; Kim, H; Pyo, H; Ahn, YC; Jeong, BH
    View PubMed
  • SUPPORT CARE CANCER 2023 10.1007/s00520-023-07779-3 Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial Lee, M; Kang, D; Kang, E; Kim, S; Kim, Y; Ahn, JS; Park, S; Lee, YY; Oh, D; Noh, JM; Cho, JH
    View PubMed
  • MODERN PATHOL 2023 10.1016/j.modpat.2023.100184 Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance Hwang, S; Hong, TH; Kim, HK; Choi, YS; Zo, JI; Shim, YM; Han, J; Ahn, YC; Pyo, H; Noh, JM; Lee, HY; Kim, HJ; Park, S; Ahn, MJ; Park, K; Lee, SH; Choi, YL; Kim, J
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1119173 Reduced radiation exposure to circulating blood cells in proton therapy compared with X-ray therapy in locally advanced lung cancer: Computational simulation based on circulating blood cells Kim, N; Shin, J; Ahn, SH; Pyo, H; Noh, JM; Yang, K; Lee, W; Park, B
    View PubMed
  • INT J RADIAT ONCOL 2023 10.1016/j.ijrobp.2022.07.018 Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer Kim, KH; Pyo, H; Lee, H; Oh, D; Noh, JM; Ahn, YC; Kim, CG; Yoon, HI; Lee, J; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ku, BM; Shin, EC; Ahn, MJ
    View PubMed
  • INT J MOL SCI 2022 10.3390/ijms232415539 Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model Kim, Y; Park, K; Kim, YJ; Shin, SW; Kim, YJ; Choi, C; Noh, JM
    View PubMed
  • RADIOTHER ONCOL 2022 10.1016/j.radonc.2022.09.003 A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases Kim, K; Il Yu, J; Park, HC; Yoo, GS; Lim, D; Noh, JM; Jeong, WK
    View PubMed
  • CANCERS 2022 10.3390/cancers14174152 Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer Bae, BK; Yang, K; Noh, JM; Pyo, H; Ahn, YC
    View PubMed
  • CANCERS 2022 10.3390/cancers14153627 Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer Suh, YG; Noh, JM; Lee, DY; Kim, TH; Bayasgalan, U; Pyo, H; Moon, SH
    View PubMed
  • INT J RADIAT ONCOL 2022 10.1016/j.ijrobp.2022.02.003 Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Kim, KH; Pyo, H; Lee, H; Oh, D; Noh, JM; Ahn, YC; Yoon, HI; Moon, H; Lee, J; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ku, BM; Ahn, MJ; Shin, EC
    View PubMed
  • EUR J CANCER 2022 10.1016/j.ejca.2022.03.034 Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer Park, S; Noh, JM; Choi, YL; Chi, SA; Kim, K; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Sun, JM
    View PubMed
  • CANCERS 2022 10.3390/cancers14061445 Prospective Study of Proton Therapy for Lung Cancer Patients with Poor Lung Function or Pulmonary Fibrosis Noh, JM; Yoo, H; Lee, W; Park, HY; Shin, SH; Pyo, H
    View PubMed
  • LIFE-BASEL 2022 10.3390/life12020292 Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer Yang, K; Suh, YG; Shin, H; Pyo, H; Moon, SH; Ahn, YC; Oh, D; Chung, E; Jo, K; Noh, JM
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2020.1349 Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx Nam, H; Ahn, YC; Yang, K; Oh, D; Noh, JM
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.151 Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue Noh, JM; Kim, YJ; Lee, HY; Choi, C; Ahn, WG; Lee, T; Pyo, H; Park, JH; Park, D; Park, WY
    View PubMed
  • J MED INTERNET RES 2021 10.2196/28695 Feasibility of an Interactive Health Coaching Mobile App to Prevent Malnutrition and Muscle Loss in Esophageal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy: Prospective Pilot Study Yang, K; Oh, D; Noh, JM; Yoon, HG; Sun, JM; Kim, HK; Zo, JI; Shim, YM; Ko, H; Lee, J; Kim, Y
    View PubMed
  • CANCERS 2021 10.3390/cancers13143497 Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis Kim, N; Noh, JM; Lee, W; Park, B; Pyo, H
    View PubMed
  • J CACHEXIA SARCOPENIA MUSCLE 2021 10.1002/jcsm.12747 Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer Yoon1, HG; Oh, D; Noh, JM; Cho, WK; Sun, JM; Kim, HK; Zo, JI; Shim, YM; Kim, K
    View PubMed
  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • CANCERS 2021 10.3390/cancers13081913 Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma Park1, J; Park, J; Shin, JH; Oh, YL; Jung, HA; Chung, MK; Choe, JH; Ahn, YC; Kim, SW; Chung, JH; Kim, TH; Noh, JM
    View PubMed
  • CANCERS 2021 10.3390/cancers13071549 Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients Yoon1, HG; Ahn, YC; Oh, D; Noh, JM; Park, SG; Nam, H; Ju, SG; Kwon, D; Park, S
    View PubMed
  • ORAL ONCOL 2021 10.1016/j.oraloncology.2021.105180 Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients Yang1, K; Ahn, YC; Nam, H; Hong, SD; Oh, D; Noh, JM
    View PubMed
  • RADIOTHER ONCOL 2021 10.1016/j.radonc.2020.12.019 Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy Kim1, N; Noh, JM; Lee, W; Park, B; Park, H; Park, JY; Pyo, H
    View PubMed
  • J THORAC DIS 2020 10.21037/jtd-20-667 Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD a cohort study Kang1, N; Shin, SH; Noh, JM; Kang, D; Kim, H; Kwon, OJ; Pyo, H; Ahn, YC; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM; Cho, J; Park, HY
    View PubMed
  • LASER MED SCI 2020 10.1007/s10103-020-03123-x Effect of photobiomodulation therapy on radiodermatitis in a mouse model an experimental animal study Park1, JH; Byun, HJ; Kim, HJ; Oh, SJ; Choi, C; Noh, JM; Oh, D; Lee, JH; Lee, DY
    View PubMed
  • LUNG CANCER 2020 10.1016/j.lungcan.2020.05.035 Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer Jung1, HA; Noh, JM; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Pyo, H; Ahn, YC; Park, K
    View PubMed
  • LASER MED SCI 2020 10.1007/s10103-019-02930-1 Feasibility of photobiomodulation therapy for the prevention of radiodermatitis a single-institution pilot study Park1, JH; Byun, HJ; Lee, JH; Kim, H; Noh, JM; Kim, CR; Oh, D
    View PubMed
  • CANCERS 2020 10.3390/cancers12040925 Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer Yoon1, HG; Oh, D; Ahn, YC; Noh, JM; Pyo, H; Cho, WK; Song, YM; Park, M; Hwang, NY; Sun, JM; Kim, HK; Zo, JI; Shim, YM
    View PubMed
  • RADIAT ONCOL 2020 10.1186/s13014-020-1464-0 Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer Yang1, K; Kim, H; Choi, DH; Park, W; Noh, JM; Cho, WK
    View PubMed
  • HEAD NECK-J SCI SPEC 2020 10.1002/hed.26067 Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review Lee1, T; Cho, J; Baek, CH; Son, YI; Jeong, HS; Chung, MK; Hong, SD; Ahn, YC; Oh, DR; Noh, JM; Park, K; Ahn, MJ; Kim, HJ; Kim, YK; Ko, YH
    View PubMed
  • Journal of thoracic disease 2019 10.21037/jtd.2019.10.18 Improved clinical outcomes following additional aggressive local consolidative therapy to systemic therapy for oligometastasis from lung cancer: where do we stand between "reality" and "illusion"? Nam1, H; Noh, JM; Park, SG; Ahn, YC
    View PubMed
  • Int J Chron Obstruct Pulmon Dis 2019 10.2147/COPD.S210759 Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy Kim1, H; Yoo, H; Pyo, H; Ahn, YC; Noh, JM; Ju, SG; Lee, W; Park, B; Kim, JM; Kang, N; Shin, SH; Chung, MP; Shin, S; Kim, HS; Park, M; Park, HY
    View PubMed
  • J RADIAT RES 2019 10.1093/jrr/rrz040 Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score Kim1, TG; Pyo, H; Ahn, YC; Noh, JM; Oh, D
    View PubMed
  • CANCER SCI 2019 10.1111/cas.14115 Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer Park1, SG; Ahn, YC; Oh, D; Noh, JM; Ju, SG; Kwon, D; Jo, K; Chung, K; Chung, E; Lee, W; Park, S
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.415 Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study Chung1, E; Noh, JM; Lee, KC; Kim, JH; Chung, WK; Suh, YG; Lee, JA; Seol, KH; Wu, HG; Kim, YS; Noh, OK; Park, JW; Lee, DS; Lee, J; Kim, YS; Park, WY; Kang, MK; Jo, S; Ahn, YC
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.240 Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients Cho1, WK; Oh, D; Lee, E; Kim, TG; Lee, H; Nam, H; Noh, JM; Ahn, YC
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.125 EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy Park1, SE; Noh, JM; Kim, YJ; Lee, HS; Cho, JH; Lim, SW; Ahn, YC; Pyo, H; Choi, YL; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.366 Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer Lee1, KH; Ahn, YC; Pyo, H; Noh, JM; Park, SG; Kim, TG; Lee, E; Nam, H; Lee, H; Sun, JM; Ahn, JS; Ahn, MJ; Park, K
    View PubMed
  • RADIOTHER ONCOL 2019 10.1016/j.radonc.2019.01.005 Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery Cho1, WK; Oh, D; Kim, HK; Ahn, YC; Noh, JM; Shim, YM; Zo, JI; Choi, YS; Sun, JM; Lee, SH; Ahn, MJ; Park, K; Nam, H
    View PubMed
  • J RADIAT RES 2019 10.1093/jrr/rry102 Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe? Yoo1, GS; Oh, D; Pyo, H; Ahn, YC; Noh, JM; Park, HC; Lim, DH
    View PubMed
  • BREAST 2019 10.1016/j.breast.2018.11.004 Adjuvant radiation therapy in small ductal carcinoma in situ Cho1, WK; Choi, DH; Kim, H; Noh, JM; Park, W; Cha, H
    View PubMed
  • J THORAC ONCOL 2019 10.1016/j.jtho.2018.10.158 Disparities in the Diagnosis and Treatment of Lung Cancer among People with Disabilities Shin1, DW; Cho, JH; Noh, JM; Han, H; Han, K; Park, SH; Kim, SY; Park, JH; Park, JH; Kawachi, I
    View PubMed
  • RADIAT ONCOL 2019 10.1186/s13014-019-1221-4 Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy Kim1, H; Pyo, H; Noh, JM; Lee, W; Park, B; Park, HY; Yoo, H
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2017.273 The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106) Ha1, B; Cho, KH; Moon, SH; Lee, CG; Keum, KC; Kim, YS; Wu, HG; Kim, JH; Ahn, YC; Oh, D; Noh, JM; Lee, JH; Kim, SH; Kim, WT; Oh, YT; Kang, MK; Kim, JH; Kim, JY; Cho, MJ; Kay, CS; Choi, JH
    View PubMed
  • INT J RADIAT ONCOL 2018 10.1016/j.ijrobp.2018.07.2022 Patterns of Failure Following Postoperative Radiation Therapy Based on "Tumor Bed With Margin" for Stage II to IV Type C Thymic Epithelial Tumor Lee1, KH; Noh, JM; Ahn, YC; Oh, D; Kim, J; Shim, YM; Han, JH
    View PubMed
  • J THORAC ONCOL 2017 10.1016/j.jtho.2017.09.1954 Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer Sun1, JM; Noh, JM; Oh, D; Kim, HK; Lee, SH; Choi, YS; Pyo, H; Ahn, JS; Jung, SH; Ahn, YC; Kim, J; Ahn, MJ; Zo, JI; Shim, YM; Park, K
    View PubMed
  • RADIAT ONCOL 2017 10.1186/s13014-017-0905-x Normal lung sparing Tomotherapy technique in stage III lung cancer Hong1, CS; Ju, SG; Ahn, YC; Yoo, GS; Noh, JM; Oh, D; Chung, K; Pyo, H; Jo, K
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.442 Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience Park1, H; Oh, D; Ahn, YC; Pyo, H; Noh, JM; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM
    View PubMed
  • ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652 Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy Kim1, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY
    View PubMed
  • Cancer Res Treat. 2016 Jan;48(1):106-14. doi: 10.4143/crt.2014.131. Epub 2015 Feb 12. Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. Noh JM1, Kim JM, Ahn YC, Pyo H, Kim B, Oh D, Ju SG, Kim JS, Shin JS, Hong CS, Park H, Lee E.
    View PubMed
  • Ann Surg Oncol. 2016 Dec;23(13):4368-4375. Epub 2016 Jun 24. Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy Cho JK11, Lim BW1, Kim EH2, Ko YH3, Oh D4, Noh JM4, Ahn YC4, Baek KH5, Jeong HS6.
    View PubMed
  • J Thorac Oncol. 2016 Dec;11(12):2202-2207. doi: 10.1016/j.jtho.2016.07.005. Epub 2016 Jul 14. Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease? Kim H11, Ahn YC2, Pyo H1, Oh D1, Noh JM1, Sun JM3, Ahn JS3, Ahn MJ3, Park K3, Choi YS4, Kim J4, Zo JI4, Shim YM4, Lee M5, Han J5.
    View PubMed
  • Cancer Res Treat. 2016 Oct;48(4):1187-1195. Epub 2016 Mar 9. Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules Cho WK11, Noh JM1, Ahn YC1, Oh D1, Pyo H1.
    View PubMed
  • Oncotarget. 2016 Sep 13;7(37):60639-60646. doi: 10.18632/oncotarget.10259. Clinical significance of post-surgical residual tumor burden and radiation therapy in treating patients with lacrimal adenoid cystic carcinoma Noh JM11, Lee E1, Ahn YC1, Oh D1, Kim YD2, Woo KI2, Ko YH3, Kim S3.
    View PubMed
  • Medicine (Baltimore). 2016 Aug;95(33):e4591. doi: 10.1097/MD.0000000000004591. High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma Oh D11, Noh JM, Nam H, Lee H, Kim TG, Ahn YC.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):917-27. doi: 10.4143/crt.2015.265. Epub 2015 Dec 28. The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis Song JH11, Wu HG2, Keam BS3, Hah JH4, Ahn YC5, Oh D5, Noh JM5, Park HJ5, Lee CG6, Keum KC6, Cha J6, Cho KH7, Moon SH7, Kim JY8, Chung WK9, Oh YT10, Kim WT11, Cho MJ12, Kay CS13, Kim YS14.
    View PubMed
  • Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.
    View PubMed
  • Head Neck. 2016 Apr;38 Suppl 1:E293-9. doi: 10.1002/hed.23988. Epub 2015 Jun 26. Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy Chang JH11,2, Ahn YC1, Park H1, Oh D1, Noh JM1, Sun JM3, Ahn MJ3, Park K3.
    View PubMed
  • Cancer Res Treat. 2016 Apr;48(2):537-45. doi: 10.4143/crt.2015.081. Epub 2015 Jul 14. Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer Lee H11, Ahn YC2, Oh D2, Nam H1, Noh JM2, Park SY2,3.
    View PubMed
  • Cancer Res Treat. 2016 Jan;48(1):106-14. doi: 10.4143/crt.2014.131. Epub 2015 Feb 12. Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy Noh JM11, Kim JM1, Ahn YC1, Pyo H1, Kim B1, Oh D1, Ju SG1, Kim JS1, Shin JS1, Hong CS1, Park H1, Lee E1.
    View PubMed
  • Cancer Res Treat. 2016 Jan;48(1):63-70. doi: 10.4143/crt.2014.265. Epub 2015 Mar 6. Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer Hong CS11, Oh D1, Ju SG1, Ahn YC1, Noh JM1, Chung K1, Kim JS1, Suh TS2.
    View PubMed
  • Oncoimmunology. 2015 Aug 12;5(1):e1067744. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotype Shrestha S11, Noh JM2, Kim SY1, Ham HY1, Kim YJ1, Yun YJ1, Kim MJ3, Kwon MS4, Song DK1, Hong CW1.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):645-52. doi: 10.4143/crt.2014.144. Epub 2015 Feb 12 Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer Noh JM1, Ahn YC, Lee H, Pyo H, Kim B, Oh D, Park H, Lee E, Park K, Ahn JS, Ahn MJ, Sun JM.
    View PubMed
  • Oncoimmunology. 2015 Aug 12;5(1):e1067744. eCollection 2016 Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotype. Shrestha S1, Noh JM, Kim SY, Ham HY, Kim YJ, Yun YJ, Kim MJ, Kwon MS, Song DK, Hong CW.
    View PubMed
  • Breast. 2015 Oct;24(5):637-41. doi: 10.1016/j.breast.2015.07.016. Epub 2015 Aug 14. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy. Noh JM1, Kim KH, Park W, Suh CO, Huh SJ, Choi DH, Keum KC, Kim YB.
    View PubMed
  • Radiat Oncol J. 2015 Jun;33(2):149-54. doi: 10.3857/roj.2015.33.2.149. Epub 2015 Jun 30. Exome sequencing in a breast cancer family without BRCA mutation. Noh JM1, Kim J, Cho DY, Choi DH, Park W, Huh SJ.
    View PubMed
  • Breast. 2015 Oct;24(5):637-41. doi: 10.1016/j.breast.2015.07.016. Epub 2015 Aug 14. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy Noh JM11, Kim KH2, Park W3, Suh CO4, Huh SJ1, Choi DH1, Keum KC2, Kim YB2.
    View PubMed
  • Breast Cancer Res Treat. 2015 Aug;152(3):589-99. doi: 10.1007/s10549-015-3505-1. Epub 2015 Jul 23. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy Kim KH11, Noh JM, Kim YB, Chang JS, Keum KC, Huh SJ, Choi DH, Park W, Suh CO.
    View PubMed
  • Cancer Res Treat. 2015 Jul;47(3):436-40. doi: 10.4143/crt.2013.184. Epub 2014 Nov 17. Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck Noh JM11, Ha SY2, Ahn YC1, Oh D1, Seol SW1, Oh YL2, Han J2.
    View PubMed
  • Med Phys. 2015 May;42(5):2626-37. doi: 10.1118/1.4916663. Preclinical investigation for developing injectable fiducial markers using a mixture of BaSO4 and biodegradable polymer for proton therapy Ahn SH11, Gil MS2, Lee DS2, Han Y3, Park HC3, Sohn JW4, Kim HY5, Shin EH5, Yu JI3, Noh JM3, Cho JS3, Ahn SH3, Choi DH3.
    View PubMed
  • Cancer Res Treat. 2014 Jul;46(3):243-9. doi: 10.4143/crt.2014.46.3.243. Epub 2014 Jul 15. Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06). Noh JM1, Park W, Kim JS, Koom WS, Kim JH, Choi DH, Park HC.
    View PubMed
  • J Radiat Res. 2014 May;55(3):553-8. doi: 10.1093/jrr/rrt141. Epub 2014 Jan 1 Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection. Noh JM1, Choi DH, Park H, Huh SJ, Park W, Seol SW, Jeong BK, Nam SJ, Lee JE, Kil WH.
    View PubMed
  • Radiat Oncol J. 2014 Dec;32(4):256-61. doi: 10.3857/roj.2014.32.4.256. Epub 2014 Dec 30. In vivo verification of regional hyperthermia in the liver. Noh JM1, Kim HY, Park HC, Lee SH, Kim YS, Hong SB, Park JH, Jung SH, Han Y.
    View PubMed
  • Gynecol Oncol. 2014 Mar;132(3):618-23. doi: 10.1016/j.ygyno.2014.01.043. Epub 2014 Jan 31. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10). Noh JM1, Park W, Kim YS, Kim JY, Kim HJ, Kim J, Kim JH, Yoon MS, Choi JH, Yoon WS, Kim JY, Huh SJ.
    View PubMed
  • Br J Cancer. 2014 Mar 18;110(6):1420-6. doi: 10.1038/bjc.2014.26. Epub 2014 Jan 30. Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II-III breast cancer? A multicentre retrospective study (KROG 12-05). Noh JM1, Park W, Suh CO, Keum KC, Kim YB, Shin KH, Kim K, Chie EK, Ha SW, Kim SS, Ahn SD, Shin HS, Kim JH, Lee HS, Lee NK, Huh SJ, Choi DH.
    View PubMed
  • Cancer Genet. 2014 Apr;207(4):160-3. doi:10.1016/j.cancergen.2014.04.002. Epub 2014 Apr 12. Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population. Noh JM1, Choi DH, Baek H, Kim MJ, Park H, Huh SJ, Park W, Nam SJ, Lee JE, Kil WH, Haffty BG.
    View PubMed
  • Breast. 2014 Oct;23(5):586-90. doi: 10.1016/j.breast.2014.05.025. Epub 2014 Jun 23. Excision alone for small size ductal carcinoma in situ of the breast. Kim H1, Noh JM, Choi DH, Lee J, Nam SJ, Lee JE, Park W, Huh SJ.
    View PubMed
  • Int J Radiat Biol. 2014 Jan;90(1):90-4. doi: 10.3109/09553002.2013.835504. Epub 2013 Sep 19. Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations. Park H1, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, Lee JE.
    View PubMed
  • J Breast Cancer. 2013 Sep;16(3):308-14. doi:10.4048/jbc.2013.16.3.308. Epub 2013 Sep 30. Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation. Noh JM1, Han BK, Choi DH, Rhee SJ, Cho EY, Huh SJ, Park W, Park H, Nam SJ, Lee JE, Kil WH.
    View PubMed
  • Breast. 2013 Oct;22(5):894-7. doi: 10.1016/j.breast.2013.04.001. Epub 2013 May 3. HER-2 overexpression is not associated with increased ipsilateral breast tumor recurrence in DCIS treated with breast-conserving surgery followed by radiotherapy. Noh JM1, Lee J, Choi DH, Cho EY, Huh SJ, Park W, Nam SJ, Lee JE, Kil WH.
    View PubMed
  • J Radiat Res. 2013 Nov 1;54(6):1036-42. doi: 10.1093/jrr/rrt066. Epub 2013 May 22. Involvement of inducible nitric oxide synthase in radiation-induced vascular endothelial damage Hong CW11, Kim YM, Pyo H, Lee JH, Kim S, Lee S, Noh JM.
    View PubMed
  • Radiat Oncol J. 2012 Dec;30(4):218-25. doi: 10.3857/roj.2012.30.4.218. Epub 2012 Dec 31. Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patients. Noh JM1, Park W, Huh SJ, Cho EY, Choi YL, Bae DS, Kim BG.
    View PubMed
  • Breast Cancer Res Treat. 2012 Jan;131(1):217-22. doi: 10.1007/s10549-011-1718-5. Epub 2011 Aug 17. Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients. Noh JM1, Choi DH, Nam SJ, Lee JE, Kim JW, Kim SW, Kang E, Lee MH, Ahn SH, Kim KS, Park SK, Haffty BG; Korea Breast Cancer Study Group.
    View PubMed
  • J Breast Cancer. 2012 Sep;15(3):283-7. doi: 10.4048/jbc.2012.15.3.283. Epub 2012 Sep 28. Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary. Noh JM1, Choi DH, Baek H, Nam SJ, Lee JE, Kim JW, Ki CS, Park W, Huh SJ
    View PubMed